THC Therapeutics in Partnership With ADVFN Announces Formation of New Company - MJAC Investorshub International Conferences L...
November 20 2017 - 7:20AM
THC Therapeutics, Inc., Inc. (OTC:THCT) (“THCT” or the “Company”)
announces that it has formed “MJAC InvestorsHub International
Conferences Limited” (“MJAC LTD”) with ADVFN PLC (LSE:AFN) of the
United Kingdom in a 50/50 partnership. MJAC LTD, which will be
headquartered in Las Vegas, Nevada, was formed to establish and
sponsor Conventions/Expos for companies, traders and investors in
the international marketplace for Cannabis, Cryptocurrencies,
Blockchain Technology, Lithium and other emerging disruptive growth
sectors. ADVFN is an 18-year-old company operating financial market
websites providing online data and services to private investors
covering more than 70 stock exchanges from across the
globe. ADVFN is a publicly listed on the London Stock
Exchange.
MJAC LTD intends to build on the huge success of
“MJAC 2017”, which was held at the JW Marriot LIVE in Los Angeles
in early September 2017. Sponsored and created by InvestorsHub, an
online investment community website in the North American market
owned by ADVFN, “MJAC 2017” featured many exhibitors and speakers
from the legal cannabis industry. The future of the legal cannabis
industry is looking bright with new investment opportunities
appearing daily. “MJAC2017” was a unique environment that allowed
industry companies to exhibit their businesses to high net worth
investors and peers. ADVFN’s
InvestorsHub.advfn.com, is a top ranked
and visited financial website with over 4.2 million unique visitors
per month. InvestorsHub has been adopted by this market
sector as the go-to website for information on equities including
the cannabis industry and cryptocurrency related investment
opportunities; among many others.
For more information on MJAC LTD, please
visit MJAC.IO
THCT and its CEO, Brandon Romanek, will be
actively involved in the operations of MJAC LTD as the company hits
the ground running to prepare for the “MJAC 2018” planned for Fall
2018; with plans for establishing future conventions/expos in the
previously mentioned sectors. With 20 years’ experience managing
businesses, Mr. Romanek’s work in the financial markets including
equities/commodities and as a broker/dealer in the precious metals
markets brings a unique expertise to MJAC LTD. Mr. Romanek also has
previous experience with financial markets conventions and MJAC LTD
is currently working to open its Las Vegas office and interview
experienced Convention/Expo and Blockchain Technology
employees.
Mr. Romanek commented, “I am extremely excited
about MJAC InvestorsHub International Conferences Limited and our
partnership with such a well-established, well-known and
well-respected company like ADVFN. I believe this new project not
only complements our current business in THCT with the many doors
our involvement opens through ADVFN and InvestorsHub, but also
provides an incredible opportunity for growth through MJAC LTD not
only in the Cannabis space, but also other emerging business
sectors like Blockchain. Cryptocurrency is the new money economy
and represents a natural progression of our current business
plan.
“Having met Clem Chambers, CEO of ADVFN, and
spent time with their board of directors as we’ve worked to
establish this partnership, I am very impressed with what they have
accomplished and their vision not only for ADVFN, but also our
shared vision for MJAC LTD as a leading force in Convention/Expo
space for these disruptive technologies,” continued Mr. Romanek.
“Given their extensive reach with the targeted players in these
sectors and the combined experience we bring from different
perspectives, I truly believe there is no limit to what we can
achieve with the successful roll-out of our current business plans
and objectives.”
Clem Chambers, CEO of ADVFN said, “After a very
pleasing start with the MJAC2017 LA show, MJAC InvestorsHub plans
to develop conferences and exhibitions focusing on disruptive
technologies including: blockchain, lithium and medical marijuana.
Linking up with THC Therapeutics leverages this opportunity with an
increased US footprint, finance and enhanced market knowledge.”
View our contract, please visit our home
page http://thctherapeutics.com
About THC Technologies, Inc.THC Therapeutics,
Inc., is focused on developing their patent-pending product, the
dHydronator®, a sanitizing herb dryer. The main function of the
dHydronator is to greatly accelerate the drying time of a herb
while sanitizing it. The dHydronator can be used to dry a variety
of herbs, and it has been specifically tested for use with
cannabis, and it will reduce the drying time for cannabis from
10-14 days to less than 14 hours. The Company is also focusing some
of its operations on participation in testing facilities and
developing personal wellness centers, as well as investigating
other potentially disruptive technologies. The Company is seeking
partnerships, mergers and acquisitions in the cannabis, health and
wellness industries. For more information, visit
THCTherapeutics.com.
Follow Brandon Romanek on Twitter:Twitter
@BrandonRomanek
Follow THC Therapeutics on Facebook and
Twitter:Twitter @THCTherapeutics Facebook
@THCTherapies
About ADVFNADVFN is a financial market website
that provides online data and services to private investors such as
stock quotes, charts, news, FOREX, Futures & Options and stock
screeners. The site currently covers in excess of 70 stock
exchanges from across the globe through multiple websites. It is
known for its active bulletin boards (internet forums). For more
information, visit uk.ADVFN.com.
Safe Harbor StatementThis press release may
contain “forward-looking statements” within the meaning of the
federal securities laws. In this context, forward-looking
statements may address the Company’s expected future business and
financial performance, and often contain words such as
“anticipates”, “beliefs”, “estimates”, “expects”, “intends”,
“plans”, “seeks”, “will”, and other terms with similar meaning.
These forward-looking statements by their nature address matters
that are, to different degrees, uncertain. Although the Company
believes that the assumptions upon which its forward-looking
statements based are reasonable, it can provide no assurances that
these assumptions will prove to be correct. All forward-looking
statements in this press release are expressly qualified by such
cautionary statements, risk, and uncertainties, and by reference to
the underlying assumptions.
Media/Investors contact: THC Therapeutics, Inc.
(702) 602-THCC (8422)Info@thctherapeutics.com
Advfn (LSE:AFN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Advfn (LSE:AFN)
Historical Stock Chart
From Sep 2023 to Sep 2024